Target Price | GBP139.21 |
Price | GBP119.46 |
Potential | 16.53% |
Number of Estimates | 26 |
26 Analysts have issued a price target AstraZeneca 2025 . The average AstraZeneca target price is GBP139.21. This is 16.53% higher than the current stock price. The highest price target is GBP199.05 66.63% , the lowest is GBP106.05 11.22% . | |
A rating was issued by 31 analysts: 23 Analysts recommend AstraZeneca to buy, 5 to hold and 3 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the AstraZeneca stock has an average upside potential 2025 of 16.53% . Most analysts recommend the AstraZeneca stock at Purchase. |
25 Analysts have issued a sales forecast AstraZeneca 2024 . The average AstraZeneca sales estimate is GBP39.3b . This is 0.80% higher than the revenue of the last 12 months(TTM). The highest sales forecast is GBP40.6b 3.96% , the lowest is GBP37.3b 4.54% .
This results in the following potential growth metrics:
2023 | GBP36.9b | 2.36% |
---|---|---|
2024 | GBP39.3b | 6.74% |
2025 | GBP42.6b | 8.19% |
2026 | GBP44.8b | 5.29% |
2027 | GBP47.5b | 5.97% |
2028 | GBP49.7b | 4.60% |
18 Analysts have issued an AstraZeneca EBITDA forecast 2024. The average AstraZeneca EBITDA estimate is GBP13.5b . This is 17.34% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is GBP16.4b 42.43% , the lowest is GBP11.5b 0.22% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | GBP11.5b | 37.82% |
---|---|---|
2024 | GBP13.5b | 17.12% |
2025 | GBP15.3b | 13.15% |
2026 | GBP16.5b | 7.82% |
2027 | GBP17.9b | 8.76% |
2028 | GBP18.3b | 2.23% |
2023 | 31.31% | 34.65% |
---|---|---|
2024 | 34.36% | 9.73% |
2025 | 35.93% | 4.57% |
2026 | 36.79% | 2.39% |
2027 | 37.76% | 2.64% |
2028 | 36.91% | 2.25% |
15 AstraZeneca Analysts have issued a net profit forecast 2024. The average AstraZeneca net profit estimate is GBP6.5b . This is 27.22% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is GBP7.3b 43.62% , the lowest is GBP5.9b 15.01% .
This results in the following potential growth metrics and future Net Margins:
2023 | GBP4.8b | 79.65% |
---|---|---|
2024 | GBP6.5b | 35.86% |
2025 | GBP8.0b | 22.96% |
2026 | GBP9.0b | 12.37% |
2027 | GBP10.5b | 16.54% |
2028 | GBP11.9b | 13.23% |
2023 | 13.00% | 75.52% |
---|---|---|
2024 | 16.54% | 27.25% |
2025 | 18.80% | 13.66% |
2026 | 20.07% | 6.76% |
2027 | 22.07% | 9.97% |
2028 | 23.89% | 8.25% |
15 Analysts have issued a AstraZeneca forecast for earnings per share. The average AstraZeneca <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is GBP4.20 . This is 27.27% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is GBP4.74 43.64% , the lowest is GBP3.80 15.15% .
This results in the following potential growth metrics and future valuations:
2023 | GBP3.09 | 79.65% |
---|---|---|
2024 | GBP4.20 | 35.92% |
2025 | GBP5.16 | 22.86% |
2026 | GBP5.80 | 12.40% |
2027 | GBP6.76 | 16.55% |
2028 | GBP7.65 | 13.17% |
Current | 36.25 | 7.50% |
---|---|---|
2024 | 28.46 | 21.49% |
2025 | 23.14 | 18.69% |
2026 | 20.60 | 10.98% |
2027 | 17.67 | 14.22% |
2028 | 15.61 | 11.66% |
Based on analysts' sales estimates for 2024, the AstraZeneca stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 5.24 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.71 .
This results in the following potential growth metrics and future valuations:
Current | 5.28 | 2.13% |
---|---|---|
2024 | 5.24 | 0.73% |
2025 | 4.84 | 7.57% |
2026 | 4.60 | 5.02% |
2027 | 4.34 | 5.63% |
2028 | 4.15 | 4.40% |
Current | 4.75 | 1.96% |
---|---|---|
2024 | 4.71 | 0.79% |
2025 | 4.35 | 7.57% |
2026 | 4.13 | 5.03% |
2027 | 3.90 | 5.63% |
2028 | 3.73 | 4.40% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.